MedPharmics, LLC
Mobile, Alabama, United States
Research institute in Mobile, Alabama
3715 Dauphin St Building 2 Suite 503B, Mobile, AL 36608
About MedPharmics, LLC
"MedPharmics is a clinical research consortium with 8 sites located in Louisiana, Mississippi, Arizona, New Mexico, and Alabama. Our sites enlist “Medical Heroes” for clinical research trials to determine the efficacy and safety of new medications or devices while ensuring the safety and protection of our participants."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at MedPharmics, LLC
During the past decade, MedPharmics, LLC conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
1996-06-01
2012-03-01
Completed
221
Combination Chemotherapy in Treating Children With Progressive Brain Tumors
1997-04-01
2012-04-01
Completed
428
Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma
1998-12-01
2007-03-01
Completed
294
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
2001-02-01
Completed
495
Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma
2000-06-01
2015-03-31
Completed
393
S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
2000-08-01
2012-07-01
Completed
432
Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma
2001-05-01
2012-03-01
Completed
66
Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate
1993-11-01
Completed
10
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at MedPharmics, LLC
According to Clinical.Site data, the most researched conditions in "MedPharmics, LLC" are
"Group B Streptococcus Infections" (1 trials) and "Respiratory Tract Infection" (1 trials). Many other conditions were trialed in "MedPharmics, LLC" in a lesser frequency.
Clinical Trials Intervention Types at MedPharmics, LLC
Most popular intervention types in "MedPharmics, LLC" are "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Multivalent Group B streptococcus vaccine" (1 trials) and "RSVpreF" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MedPharmics, LLC
The vast majority of trials in "MedPharmics, LLC" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at MedPharmics, LLC
Currently, there are NaN active trials in "MedPharmics, LLC".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in MedPharmics, LLC,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MedPharmics, LLC, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".